Glycoprotein glycans that inhibit adhesion of Escherichia coli mediated by K99 fimbriae: treatment of experimental colibacillosis.
AUTOR(ES)
Mouricout, M
RESUMO
Calf diarrhea due to infection by enterotoxigenic Escherichia coli was treated by administration of glycoprotein glycans derived from bovine plasma. The glycan moieties of the nonimmunoglobulin fraction of plasma mimicked the oligosaccharide moiety of intestinal receptors recognized by K99 pili. These glycoprotein glycans inhibited adhesion of E. coli K99+ ST+ to erythrocyte glycoconjugates in vitro, and they protected colostrum-deprived newborn calves against lethal doses of enterotoxigenic E. coli (10(10) bacteria). Adhesion of bacteria to the intestines (duodenum, jejunum, and ileum) was significantly reduced (by 2 orders of magnitude) in treated calves.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=258414Documentos Relacionados
- Vaccination of cows with a K99 extract to protect newborn calves against experimental enterotoxic colibacillosis.
- Ganglioside epitope recognized by K99 fimbriae from enterotoxigenic Escherichia coli.
- Expression of K99 adhesion antigen controlled by the Escherichia coli tryptophan operon promoter.
- K99 surface antigen of Escherichia coli: antigenic characterization.
- In vivo emergence of enterotoxigenic Escherichia coli variants lacking genes for K99 fimbriae and heat-stable enterotoxin.
